Literature DB >> 8631841

Glycation and glycoxidation of histones by ADP-ribose.

D Cervantes-Laurean1, E L Jacobson, M K Jacobson.   

Abstract

The reaction of long lived proteins with reducing sugars has been implicated in the pathophysiology of aging and age-related diseases. A likely intranuclear source of reducing sugar is ADP-ribose, which is generated following DNA damage from the turnover of ADP-ribose polymers. In this study, ADP-ribose has been shown to be a potent histone glycation and glycoxidation agent in vitro. Incubation of ADP-ribose with histones H1, H2A, H2B, and H4 at pH 7.5 resulted in the formation of ketoamine glycation conjugates. Incubation of histone H1 with ADP-ribose also rapidly resulted in the formation of protein carboxymethyllysine residues, protein-protein cross-links, and highly fluorescent products with properties similar to the advanced glycosylation end product pentosidine. The formation of glycoxidation products was related to the degradation of ketoamine glycation conjugates by two different pathways. One pathway resulted in the formation of protein carboxymethyllysine residues and release of an ADP moiety containing a glyceric acid fragment. A second pathway resulted in the release of ADP, and it is postulated that this pathway is involved in the formation of histone-histone cross-links and fluorescent advanced glycosylation end products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631841     DOI: 10.1074/jbc.271.18.10461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Endogenous protein mono-ADP-ribosylation in Arabidopsis thaliana.

Authors:  Hai Wang; Qin Liang; Kaiming Cao; Xiaochun Ge
Journal:  Planta       Date:  2011-04-26       Impact factor: 4.116

Review 2.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 3.  Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.

Authors:  Michael W Van Dyke
Journal:  ChemMedChem       Date:  2014-01-21       Impact factor: 3.466

Review 4.  Insights into the biogenesis, function, and regulation of ADP-ribosylation.

Authors:  Michael S Cohen; Paul Chang
Journal:  Nat Chem Biol       Date:  2018-02-14       Impact factor: 15.040

5.  Metabolism Dealing with Thermal Degradation of NAD+ in the Hyperthermophilic Archaeon Thermococcus kodakarensis.

Authors:  Shin-Ichi Hachisuka; Takaaki Sato; Haruyuki Atomi
Journal:  J Bacteriol       Date:  2017-09-05       Impact factor: 3.490

Review 6.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

7.  PARP1 ADP-ribosylates lysine residues of the core histone tails.

Authors:  Simon Messner; Matthias Altmeyer; Hongtao Zhao; Andrea Pozivil; Bernd Roschitzki; Peter Gehrig; Dorothea Rutishauser; Danzhi Huang; Amedeo Caflisch; Michael O Hottiger
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

8.  Side chain specificity of ADP-ribosylation by a sirtuin.

Authors:  Kamau Fahie; Po Hu; Stephen Swatkoski; Robert J Cotter; Yingkai Zhang; Cynthia Wolberger
Journal:  FEBS J       Date:  2009-11-06       Impact factor: 5.542

9.  ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine.

Authors:  Linda A Stevens; Rodney L Levine; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

10.  Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.

Authors:  Matthias Altmeyer; Simon Messner; Paul O Hassa; Monika Fey; Michael O Hottiger
Journal:  Nucleic Acids Res       Date:  2009-04-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.